AG
GILD icon

Aperio Group’s Gilead Sciences GILD Stock Holding History

Aperio Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$41M Sell
702,897
-149,620
-18% -$9.03M 0.12% 163
2020
Q3 		$53.9M Sell
852,517
-221,016
-21% -$15.3M 0.18% 98
2020
Q2 		$82.6M Sell
1,073,533
-2,938
-0.3% -$225K 0.31% 55
2020
Q1 		$80.5M Buy
1,076,471
+360,510
+50% +$24.9M 0.36% 52
2019
Q4 		$46.5M Sell
715,961
-9,402
-1% -$612K 0.17% 127
2019
Q3 		$46M Sell
725,363
-31,562
-4% -$2.06M 0.18% 114
2019
Q2 		$51.1M Buy
756,925
+64,816
+9% +$4.26M 0.21% 91
2019
Q1 		$45M Buy
692,109
+10,747
+2% +$714K 0.19% 104
2018
Q4 		$42.6M Sell
681,362
-108,729
-14% -$7.6M 0.21% 98
2018
Q3 		$61M Buy
790,091
+59,662
+8% +$4.51M 0.27% 72
2018
Q2 		$51.7M Sell
730,429
-258,005
-26% -$18.2M 0.25% 80
2018
Q1 		$74.5M Buy
988,434
+17,952
+2% +$1.43M 0.37% 47
2017
Q4 		$69.5M Buy
970,482
+64,620
+7% +$4.91M 0.35% 51
2017
Q3 		$73.4M Buy
905,862
+119,265
+15% +$9.12M 0.41% 43
2017
Q2 		$55.7M Buy
786,597
+234,180
+42% +$15.6M 0.34% 55
2017
Q1 		$37.5M Buy
552,417
+32,816
+6% +$2.31M 0.26% 83
2016
Q4 		$37.2M Sell
519,601
-30,895
-6% -$2.3M 0.28% 72
2016
Q3 		$43.6M Buy
550,496
+10,321
+2% +$838K 0.32% 67
2016
Q2 		$45.1M Sell
540,175
-18,976
-3% -$1.68M 0.35% 58
2016
Q1 		$51.4M Buy
559,151
+7,593
+1% +$685K 0.44% 43
2015
Q4 		$55.8M Buy
551,558
+4,390
+0.8% +$457K 0.51% 31
2015
Q3 		$53.7M Buy
547,168
+38,133
+7% +$4.24M 0.55% 28
2015
Q2 		$59.6M Buy
509,035
+56,444
+12% +$6.17M 0.62% 21
2015
Q1 		$44.4M Buy
452,591
+35,153
+8% +$3.57M 0.5% 28
2014
Q4 		$39.3M Buy
417,438
+14,296
+4% +$1.48M 0.48% 31
2014
Q3 		$42.9M Buy
403,142
+37,709
+10% +$3.69M 0.58% 23
2014
Q2 		$30.3M Buy
365,433
+21,528
+6% +$1.68M 0.44% 36
2014
Q1 		$24.4M Buy
+343,905
New +$27M 0.34% 48
2013
Q4 		– Sell
-286,538
Closed -$20M – 38
2013
Q3 		$18M Buy
286,538
+44,713
+18% +$2.67M 0.35% 45
2013
Q2 		$12.4M Buy
+241,825
New +$12.6M 0.29% 60

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aperio Group's GILD Position: Q4 2020 in Review

Aperio Group reduced its Gilead Sciences (GILD) stake by 18% in Q4 2020, selling an estimated $9.03M and leaving 702,897 shares worth $41M. The position accounts for 0.12% of the portfolio, ranked #163.

Aperio Group first reported a position in GILD in Q2 2013 and has held it in 30 quarters since. The position peaked at $82.6M in Q2 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Aperio Group held 702,897 shares of Gilead Sciences worth $41M as of Q4 2020.
  • Aperio Group sold 149,620 Gilead Sciences shares in Q4 2020, an estimated $9.03M.
  • Gilead Sciences made up 0.12% of Aperio Group's portfolio in Q4 2020, its #163 holding.
  • Aperio Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 30 quarters since.
  • Aperio Group's Gilead Sciences position peaked at $82.6M in Q2 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.